News
First, Oracle is experiencing a transition period -- effectively replacing slow-growth (or no-growth) segments of the ...
The controversy over Jeffrey Epstein rumbles on, despite President Trump’s efforts to put it behind him. It’s been almost ...
Voters have increasingly little faith in the Democrats, a new Wall Street Journal poll found, with the party reaching its ...
House Democrats sent a letter to lawyers of Jeffrey Epstein's estate on July 25 seeking a copy of Epstein's so-called ...
You’re making a very big thing over something that’s not a big thing,” President Donald Trump told reporters questioning him ...
The leading role the former “first buddy” took in stoking the Epstein controversy shows how he remains a potent political ...
Besides Wall Street, Arista Networks is growing increasingly popular with customers. The company's industry-leading switches ...
While investors get excited about the potential of robotaxis, EV makers will face severe financial challenges in 2025 and ...
With no sign of the political firestorm ending, Trump urges his Justice Department to pursue former President Barack Obama ...
As reported by the New York Times, there’s widespread confusion over what Medicare and Medicaid cover and pay for when it ...
Palantir (NASDAQ:PLTR) is a colossal winner that’s just found a way to keep winning in 2025. With shares up more than 37% in ...
Among the strongest performers, Thermo Fisher Scientific rose 12%, topping the leaderboard for large-cap stocks, followed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results